Additionally, TRIP12 regulates response to PARP inhibitors in breast cancer cells [22] and we have shown that the genetic inhibition of TRIP12 leads to the stabilisation of FBW7 protein, mitotic arrest, and enhanced cell death in response to Taxol treatment [23, 24]. Here, TRIP12 is linked to breast cancer.